Michael joined Killik & Co in 2012 having previously covered pharmaceutical equities for an R&D newswire after graduating in Biochemistry from Imperial College London.
Michael now specialises in developing long-term relationships with clients and advising them on how best to achieve their financial goals. Michael is a Member of the Chartered Institute of Securities and Investment.
45 Cadogan Street
Nearest Tube: Sloane Square
+44 (0) 207 337 0590